论文部分内容阅读
AIM To evaluate the therapeutic effects of bonemarrow-derived mesenchymal stem cells (BMSCs) with human urokinase-type plasminogen activator (uPA) onliver fibrosis, and to investigate the mechanism of genetherapy.METHODS: BMSCs transfected with adenovirus